Fabrice Carrat to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Fabrice Carrat has written about Carcinoma, Hepatocellular.
Connection Strength
0.831
-
Direct-acting antivirals and the risk of hepatocellular carcinoma: The end of a polemic? Liver Int. 2019 03; 39(3):446-447.
Score: 0.369
-
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet. 2019 Apr 06; 393(10179):1453-1464.
Score: 0.368
-
Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules - A response. J Hepatol. 2019 08; 71(2):446.
Score: 0.094